{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:57:44Z","timestamp":1777651064808,"version":"3.51.4"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,12]],"date-time":"2018-08-12T00:00:00Z","timestamp":1534032000000},"content-version":"vor","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.mehy.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T17:16:41Z","timestamp":1502212601000},"page":"94-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Phosphodiesterases and preeclampsia"],"prefix":"10.1016","volume":"108","author":[{"given":"Anne Brandolt","family":"Larr\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Parisotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna Fagundes","family":"Rockenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora Montenegro","family":"Pasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia","family":"Capellari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele Cristov\u00e3o","family":"Escouto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartira Erc\u00edlia","family":"Pinheiro da Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo","family":"Poli-de-Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2017.08.003_b0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregn Hypertens"},{"key":"10.1016\/j.mehy.2017.08.003_b0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the national high blood pressure education program working group on high blood pressure in pregnancy","volume":"183","author":"NHBPEPWGHBPP- National High Blood Pressure Education Program","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.mehy.2017.08.003_b0020","doi-asserted-by":"crossref","first-page":"f6564","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980\u20132010:age-period-cohort analysis","volume":"347","author":"Ananth","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2017.08.003_b0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1081\/PRG-200030301","article-title":"Maternal deaths associated with hypertensive disorders of pregnancy: a population-based study","volume":"23","author":"Moodley","year":"2004","journal-title":"Hypertens Pregn"},{"key":"10.1016\/j.mehy.2017.08.003_b0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.mehy.2017.08.003_b0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of preeclampsia","volume":"357","author":"Robert","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2017.08.003_b0040","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2017.08.003_b0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"Redman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0050","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1447-0756.2011.01771.x","article-title":"Role of oxidative stress in preeclampsia and intrauterine growth restriction","volume":"38","author":"Mert","year":"2012","journal-title":"J Obstet Gynecol Res"},{"key":"10.1016\/j.mehy.2017.08.003_b0055","first-page":"243476","article-title":"Antioxidants for preventing preeclampsia: a systematic review","author":"Salles","year":"2012","journal-title":"Sci World J"},{"key":"10.1016\/j.mehy.2017.08.003_b0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.placenta.2008.09.015","article-title":"Altered global gene expression in first trimester placentas of women destined to develop preeclampsia","volume":"30","author":"Founds","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2017.08.003_b0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"NEJM"},{"key":"10.1016\/j.mehy.2017.08.003_b0070","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.mehy.2017.08.003_b0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bcp.12301","article-title":"The nitric oxide pathway and possible therapeutic options in pre-eclampsia","volume":"78","author":"Johal","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2017.08.003_b0080","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/jog.12825","article-title":"Vascular endothelial growth factor (VEGF)-634G\/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level","volume":"41","author":"Salimi","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.mehy.2017.08.003_b0085","first-page":"182","article-title":"Flow-mediated dilatation in the differential diagnosis of preeclampsia syndrome","volume":"94","author":"Filho","year":"2010","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.mehy.2017.08.003_b0090","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/j.ijcard.2013.05.014","article-title":"Flow-mediated dilatation of brachial artery as marker of preeclampsia morbidity","volume":"168","author":"Vieira","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.mehy.2017.08.003_b0095","first-page":"373","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"3","author":"Furchgott","year":"1998","journal-title":"Dialog Cardiovasc Med"},{"key":"10.1016\/j.mehy.2017.08.003_b0100","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0021-9258(18)60316-3","article-title":"Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine","volume":"237","author":"Butcher","year":"1962","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2017.08.003_b0105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.RES.0000087541.15600.2B","article-title":"Cyclic GMP phosphodiesterases and regulation of smooth muscle function","volume":"93","author":"Rybalkin","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2017.08.003_b0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mehy.2017.08.003_b0115","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ajog.2003.12.024","article-title":"Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries","volume":"190","author":"Wareing","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-0528.2006.00916.x","article-title":"Increased serum phosphodiesterase activity in women with pre-eclampsia","volume":"133","author":"Pinheiro da Costa","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.mehy.2017.08.003_b0125","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.mehy.2004.03.042","article-title":"Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia","volume":"63","author":"Downing","year":"2004","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2017.08.003_b0130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14728214.2015.1062875","article-title":"Emerging drugs for preeclampsia - the endothelium as a target","volume":"20","author":"Sasser","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.mehy.2017.08.003_b0135","doi-asserted-by":"crossref","first-page":"R397","DOI":"10.1152\/ajpregu.00216.2013","article-title":"Sildenafil attenuates placental ischemia-induced hypertension","volume":"305","author":"George","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.mehy.2017.08.003_b0140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ajog.2005.05.054","article-title":"Expression of phosphodiesterase 5 in maternal and fetal sheep","volume":"193","author":"Coppage","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0145","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.bbrc.2006.01.035","article-title":"Subcellular localization and regulation of type-1C and type-5 phosphodiesterases","volume":"341","author":"Dolci","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2017.08.003_b0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejogrb.2004.06.014","article-title":"Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and pre-eclampsia","volume":"127","author":"Wareing","year":"2006","journal-title":"Eur J Obstret Gynecol Reprod Biol"},{"key":"10.1016\/j.mehy.2017.08.003_b0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.preghy.2011.04.002","article-title":"Different effects of different phosphodiesterase type-5 inhibitors in pre-eclampsia","volume":"1","author":"Karasu","year":"2011","journal-title":"Pregn Hypertens: Int J Womens Cardiovasc Health"},{"key":"10.1016\/j.mehy.2017.08.003_b0160","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.placenta.2014.02.005","article-title":"In vivo 31 P-MR spectroscopy in normal pregnancy, early and late preeclampsia: a study of placental metabolism","volume":"35","author":"Sohlberg","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2017.08.003_b0165","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2017.08.003_b0170","unstructured":"American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122\u201331."},{"key":"10.1016\/j.mehy.2017.08.003_b0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9378(16)32330-4","article-title":"Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy","volume":"142","author":"Weinstein","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0180","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/HYPERTENSIONAHA.111.00250","article-title":"Redefining preeclampsia using placenta-derived biomarkers","volume":"61","author":"Staff","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2017.08.003_b0185","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","author":"Burton","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2017.08.003_b0190","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/HYPERTENSIONAHA.110.157743","article-title":"Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health","volume":"56","author":"Staff","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2017.08.003_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/jmcc.1998.0844","article-title":"Endothelial dysfunction: from physiology to therapy","volume":"31","author":"Mombouli","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.mehy.2017.08.003_b0200","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1001\/jama.285.12.1607","article-title":"Association of maternal endothelial dysfunction with preeclampsia","volume":"285","author":"Chambers","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2017.08.003_b0205","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2017.08.003_b0210","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.274.35.25130","article-title":"Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1\/KDR activation of c-Src","volume":"274","author":"He","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2017.08.003_b0215","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia a prospective multicenter study","volume":"128","author":"Chappel","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2017.08.003_b0220","doi-asserted-by":"crossref","first-page":"e0164276","DOI":"10.1371\/journal.pone.0164276","article-title":"Placental Growth Factor (PlGF) in women with suspected pre-eclampsia prior to 35 weeks\u2019 gestation: a budget impact analysis","volume":"11","author":"Duckworth","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2017.08.003_b0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0020-7292(99)00213-1","article-title":"EL-dien HM. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia","volume":"68","author":"Shaamash","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.mehy.2017.08.003_b0230","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/10641955.2016.1139718","article-title":"Serum nitrate and NOx levels in preeclampsia are higher than in normal pregnancy","volume":"35","author":"Acauan Filho","year":"2016","journal-title":"Hypertens Pregn"},{"key":"10.1016\/j.mehy.2017.08.003_b0235","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"NEJM"},{"key":"10.1016\/j.mehy.2017.08.003_b0240","first-page":"208","article-title":"Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy","volume":"18","author":"Baylis","year":"1998","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.mehy.2017.08.003_b0245","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ajog.2003.08.042","article-title":"L-arginine erythrocyte transport in normal pregnant and preeclamptic women","volume":"190","author":"da Costa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0250","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0002-9378(94)70064-8","article-title":"The role of nitric oxide in the pathogenesis of preeclampsia","volume":"171","author":"Seligman","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0255","first-page":"F48","article-title":"Plasma and 24-h NOx and cGMP during normal pregnancy and preeclampsia in women on a reduced NOx diet","volume":"277","author":"Conrad","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mehy.2017.08.003_b0260","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/j.1600-0412.1998.770805.x","article-title":"Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia","volume":"77","author":"Pettersson","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.mehy.2017.08.003_b0265","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.placenta.2015.02.001","article-title":"Placental expression of eNOS, iNOS and the major protein components of caveolae in women with pre-eclampsia","volume":"36","author":"Smith-Jackson","year":"2015","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2017.08.003_b0270","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1097\/01.ASN.0000034201.97937.3E","article-title":"Efficacy of Oral Sildenafil in Hemodialysis Patients with Erectile Dysfunction","volume":"13","author":"Seibel","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mehy.2017.08.003_b0275","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrd2030","article-title":"Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond","volume":"5","author":"Ghofrani","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mehy.2017.08.003_b0280","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejphar.2008.04.034","article-title":"The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model","volume":"589","author":"Turgut","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2017.08.003_b0285","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/10641950802601278","article-title":"A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia","volume":"28","author":"Samangaya","year":"2009","journal-title":"Hypertens Pregn"},{"key":"10.1016\/j.mehy.2017.08.003_b0290","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1042\/BIO03805022","article-title":"Linking cardiovascular disease, erectile dysfunction and preeclampsia: no problem","volume":"38","author":"Burke","year":"2016","journal-title":"The Biochemist"},{"key":"10.1016\/j.mehy.2017.08.003_b0295","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.mehy.2017.08.003_b0300","unstructured":"Sigma Aldrich. Phosphodiesterases. http:\/\/www.sigmaaldrich.com\/technical-documents\/articles\/biology\/rbi-handbook\/intracellular-signaling-enzymes receptors\/ phosphodiesterases.html. Accessed on: September 14th, 2016."},{"key":"10.1016\/j.mehy.2017.08.003_b0305","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2007.12.017","article-title":"PDE4 and PDE5 regulate cyclic nucleotide relaxing effects in human umbilical arteries","volume":"582","author":"Santos-Silva","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2017.08.003_b0310","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1210\/jc.2004-1831","article-title":"Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction","volume":"90","author":"Wareing","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2017.08.003_b0315","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/AOG.0000000000001518","article-title":"Perinatal and hemodynamic evaluation of sildenafil citrate for preeclampsia treatment: a randomized controlled trial","volume":"128","author":"Trapani","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0320","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1093\/nar\/21.17.4085","article-title":"Purification and cDNA cloning of HeLa cell P54nrb, a nuclear protein with two RNA recognition motifs and extensive homology to human splicing factor PSF and Drosophila nonA\/BJ6","volume":"21","author":"Dong","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.mehy.2017.08.003_b0325","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1128\/MCB.13.9.5593","article-title":"NonO, a non-POU-domain-containing, octamer-binding protein, is the mammalian homolog of Drosophila nonAdiss","volume":"13","author":"Yang","year":"1993","journal-title":"Mol Cel Biol"},{"key":"10.1016\/j.mehy.2017.08.003_b0330","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1017\/S1355838202025037","article-title":"Splicing and transcription-associated proteins PSF and p54nrb\/NONO bind to the RNA polymerase II CTD","volume":"8","author":"Emili","year":"2002","journal-title":"RNA"},{"key":"10.1016\/j.mehy.2017.08.003_b0335","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/MCB.00993-14","article-title":"P54nrb\/NONO regulates cyclic amp-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation","volume":"35","author":"Lu","year":"2015","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.mehy.2017.08.003_b0340","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jemt.10339","article-title":"ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in adrenal cortex","volume":"61","author":"Sewer","year":"2003","journal-title":"Microscop Res Tech"},{"key":"10.1016\/j.mehy.2017.08.003_b0345","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/0002-9378(90)90639-O","article-title":"Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia","volume":"163","author":"August","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0350","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1210\/jcem-54-5-1010","article-title":"Changes in active and inactive renin throughout pregnancy","volume":"54","author":"Hsueh","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2017.08.003_b0355","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/cs0790403","article-title":"Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy","volume":"79","author":"Baker","year":"1990","journal-title":"Clin Sci"},{"key":"10.1016\/j.mehy.2017.08.003_b0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/cs0830089","article-title":"Comparative study of platelet angiotensin II binding and the angiotensin II sensitivity test as predictors of pregnancy-induced hypertension","volume":"83","author":"Baker","year":"1992","journal-title":"Clin Sci"},{"key":"10.1016\/j.mehy.2017.08.003_b0365","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1172\/JCI107462","article-title":"A study of angiotensin II pressor response throughout primigravid pregnancy","volume":"52","author":"Gant","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2017.08.003_b0370","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9378(65)90462-X","article-title":"Vascular reactivity to angiotensin II and norepinephrine in pregnant and nonpregnant women","volume":"91","author":"Chesley","year":"1965","journal-title":"Am J Obstet Gynecol"},{"issue":"7590","key":"10.1016\/j.mehy.2017.08.003_b0375","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(69)91302-6","article-title":"Prospective study of plasma-renin activity in normal and toxaemic pregnancy","volume":"1","author":"Gordon","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2017.08.003_b0380","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9378(16)34536-7","article-title":"Angiotensin blood levels in normal and toxemic pregnancies","volume":"99","author":"Massani","year":"1967","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0385","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.placenta.2010.02.014","article-title":"Expression of AT1R, AT2R and AT4R and their roles in extravillous trophoblast invasion in the human","volume":"31","author":"Williams","year":"2010","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2017.08.003_b0390","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.placenta.2012.11.027","article-title":"The placental renin-angiotensin system and oxidative stress in pre-eclampsia","volume":"34","author":"Mistry","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2017.08.003_b0395","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1113\/JP271045","article-title":"Human placental renin-angiotensin system in normotensive and pre-eclamptic pregnancies at high altitude and after acute hypoxia-reoxygenation insult","volume":"594","author":"Kurlak","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.mehy.2017.08.003_b0400","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.placenta.2011.09.020","article-title":"The expression and localization of the human placental prorenin\/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis?","volume":"32","author":"Pringle","year":"2011","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2017.08.003_b0405","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1874192401004010302","article-title":"The endothelium and its role in regulating vascular tone","volume":"4","author":"Sandoo","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"10.1016\/j.mehy.2017.08.003_b0410","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1067\/mob.2002.127378","article-title":"Endothelial dysfunction in uterine circulation in preeclampsia: can estrogens improve it?","volume":"187","author":"Svedas","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0415","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1067\/mob.2003.110","article-title":"Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women","volume":"188","author":"Svedas","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2017.08.003_b0420","first-page":"356","article-title":"Prostacyclin and thromboxane changes predating clinical onset of preeclampsia. A multicenter prospective study","volume":"281","author":"Mills","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2017.08.003_b0425","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.mam.2007.02.006","article-title":"The role of the immune system in preeclampsia","volume":"28","author":"Saito","year":"2007","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.mehy.2017.08.003_b0430","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fphys.2014.00372","article-title":"Endothelial dysfunction and preeclampsia: role of oxidative stress","volume":"5","author":"S\u00e1nchez-Aranguren","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.mehy.2017.08.003_b0435","first-page":"5","article-title":"Determination of Interleukin-6 and Tumor Necrosis Factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia","author":"Afshari","year":"2005","journal-title":"BMC Pregn Child"},{"key":"10.1016\/j.mehy.2017.08.003_b0440","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.HYP.0000238442.33463.94","article-title":"Hypertension produced by reductions in uterine perfusion in the pregnant rat role of interleukin 6","author":"Gadonski","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2017.08.003_b0445","first-page":"121","article-title":"Increased levels of the soluble receptor of Interleukin-6 in patients with preeclampsia compared to normotensive pregnant women","volume":"23","author":"Hentschke","year":"2014","journal-title":"Scientia Medica"},{"key":"10.1016\/j.mehy.2017.08.003_b0450","first-page":"1707","article-title":"Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity","volume":"16","author":"Ozler","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.mehy.2017.08.003_b0455","first-page":"1","article-title":"Soluble TNF-Like weak inducer of apoptosis as a new marker in preeclampsia: a pilot clinical study","volume":"2016","author":"Zeynep","year":"2016","journal-title":"Dis Markers"},{"key":"10.1016\/j.mehy.2017.08.003_b0460","first-page":"219","article-title":"The role of cytokines as inflammatory mediators in preeclampsia","volume":"20","author":"Udenze","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.mehy.2017.08.003_b0465","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cyto.2011.09.021","article-title":"A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia","volume":"56","author":"Xie","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.mehy.2017.08.003_b0470","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.HYP.0000113044.46326.98","article-title":"Reduced endothelial NO-cGMP-mediated vascular relaxation and hypertension in IL-6-infused pregnant rats","volume":"43","author":"Orshal","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2017.08.003_b0475","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-0378(02)00085-2","article-title":"Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction","volume":"59","author":"Tjoa","year":"2003","journal-title":"J Reprod Immunol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716306946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716306946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T18:11:29Z","timestamp":1659291089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716306946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":95,"alternative-id":["S0306987716306946"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2017.08.003","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphodiesterases and preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}